Taiwan FDA registration d4b4ddefdded47ed5c465ab05ef1e741

Bondis Human Immunoglobulin G Subtype Test Kit

TW: 邦迪斯人類免疫球蛋白G亞型檢驗試劑套組

Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Sep 30, 2010 – Sep 30, 2020Cancelled

Registration details

Analysis ID: d4b4ddefdded47ed5c465ab05ef1e741
Customs Code: DHA00602155305

Company information

Manufacturer: THE BINDING SITE GROUP LIMITED
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This panel is intended for in vitro diagnostic use to quantify human serum immunoglobulin G subtypes. This kit is available for Hitachi 911/912/917/Hitachi Modular P instruments.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
Import Information: import

Dates and status

Registration Date: Sep 30, 2010
Expiry Date: Sep 30, 2020
Cancellation Date: May 19, 2022

Cancellation information

Status: Logged out
Reason: 自行鍵入

About this record

Access comprehensive regulatory information for Bondis Human Immunoglobulin G Subtype Test Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d4b4ddefdded47ed5c465ab05ef1e741 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.